{"SPADE_UN_08104": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 7001924 B2", "Patent Link": "http://www.lens.org/lens/patent/US_7001924_B2", "Patent Type": "Granted Patent", "Publication Date": "2006-2-21", "Family Info": "EP1435932A2,EP1435932A4,US20030134904,WO2003024407A2,WO2003024407A3", "Patent Title": "Inhibitors of RNase P proteins as antibacterial compounds.", "Abstract": "The present invention features compounds useful for inhibiting RNase P activity. These compounds can be used as therapeutics for treating or preventing a variety of bacterial infections. The compounds belong to several classes including mono- and bis-guanylhydrazones, guanylhydrazone mimetics, and benzothiazolium compounds. Exemplary compounds are compounds of formula I: \nYâ€”(NRâ€²)kâ€”U1â€”(NRâ€³)Iâ€”Aâ€”(NR1)mâ€”U2â€”(NR2)nâ€”Zâ€ƒâ€ƒI with substituents as described herein."}], "Sequence Information": {"SPADE ID": "SPADE_UN_08104", "Sequence": "YRIKKNADFQRIYRLGISVSKKLGNAVLRNKIKRAIRENFKVHKSHIDIIVIARQPAKDMTTLQIQNSLE", "Sequence Length": 70, "Peptide Name": "Sequence 101 from Patent US 7001924", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "IKR", "Absent Amino Acids": "COUW", "Basic Residues": 18, "Acidic Residues": 5, "Hydrophobic Residues": 30, "Polar Residues": 44, "Positive Residues": 18, "Negative Residues": 5, "Mass": 8188.57, "PI": 10.82, "Net Charge": 13, "Hydrophobicity": -0.49, "Similar Sequences": [{"SPADE_ID": "SPADE_N_05781", "Similarity": 1.0, "Sequence": "HLLEKAYRIKKNADFQRIYKKGHSVANRQFWYTCNNKEIDHFRLGISVSKKLGNAVLRNKIKRAIRENFKVHKSHILAKDIIVIARQPAKDMTTLQIQNS"}, {"SPADE_ID": "SPADE_N_05782", "Similarity": 0.9565217391304348, "Sequence": "MLLEKAYRIKKNADFQRIYKKGHSVANRQFWYTCNNKEIDHFRLGISVSKKLGNAVLRNKIKRAIRENFKVHKSHLAKDIVIARQPAKDMTTLQIQNSL"}, {"SPADE_ID": "SPADE_UN_18531", "Similarity": 0.8695652173913043, "Sequence": "YRIKKNADFQRLGISVSKKLGNAVLRNKIKRAIREILDIIVIQNSL"}]}}}